FTC opens investigation into Teva, escalating patent fight with pharmaceutical industry
The Federal Trade Commission has opened an investigation into Teva Pharmaceuticals, citing the company’s refusal to drop about two dozen patents for its asthma and COPD inhalers, according to confidential agency documents reviewed by The Washington Post. The FTC last week sent a civil investigative demand — effectively a subpoena — ordering Teva to provide … Read more
